|
Inflection Point Acquisition Corp. Iii Rights 2025-
|
04/12
|
0,3779
|
-1,43%
|
0,4
|
0,37 - 0,4
|
|
Inflection Point Acquisition Corp. Iii Units Cons Of
|
26/11
|
10,5
|
0,00%
|
0
|
---
|
|
Inflection Point Acquisition Corp. Iv
|
04/12
|
10,73
|
+0,75%
|
10,6449
|
10,63 - 10,801
|
|
Inflection Point Acquisition Corp. Iv Rights 2024-
|
04/12
|
0,77
|
+1,99%
|
0,76
|
0,735 - 0,77
|
|
Inflection Point Acquisition Corp. Iv Units Cons Of
|
04/12
|
11,45
|
-6,30%
|
11,31
|
11,3 - 11,45
|
|
Inflection Point Acquisition Corp. V
|
04/12
|
10,3
|
0,00%
|
0
|
10,25 - 10,3
|
|
Inflection Point Acquisition Corp. V Rights
|
03/12
|
0,96
|
0,00%
|
0
|
---
|
|
Inflection Point Acquisition Corp. V Units Cons Of
|
03/12
|
12
|
0,00%
|
0
|
---
|
|
Infobird
|
04/12
|
1,13
|
+16,83%
|
0,98
|
0,96 - 1,14
|
|
Information Services
|
04/12
|
5,77
|
+2,12%
|
5,66
|
5,595 - 5,83
|
|
Ingles Markets, Incorporated
|
04/12
|
76,18
|
-1,87%
|
77,1
|
75,43 - 77,1
|
|
Inhibikase Therapeutics
|
04/12
|
1,51
|
+4,86%
|
1,45
|
1,45 - 1,56
|
|
Inhibrx Biosciences
|
04/12
|
87,41
|
+5,36%
|
81,92
|
81,485 - 89,4303
|
|
Inlif
|
04/12
|
0,6666
|
+11,10%
|
0,6527
|
0,57 - 0,7379
|
|
Inmed Pharmaceuticals
|
04/12
|
1,34
|
0,00%
|
1,26
|
1,25 - 1,37
|
|
Inmode Ltd
|
04/12
|
14,34
|
-0,69%
|
14,44
|
14,305 - 14,5491
|
|
Inmune Bio
|
04/12
|
1,88
|
+6,82%
|
1,74
|
1,69 - 1,915
|
|
Innate Pharma
|
04/12
|
1,91
|
+0,53%
|
0
|
1,89 - 1,95
|
|
Inneova Holdings
|
04/12
|
0,6621
|
+1,12%
|
0,6623
|
0,662 - 0,7066
|
|
Inno Holdings
|
04/12
|
0,1388
|
+1,02%
|
0,128
|
0,1178 - 0,1514
|